Segui
Charlotte K Y Ng
Charlotte K Y Ng
Email verificata su dbmr.unibe.ch
Titolo
Citata da
Citata da
Anno
Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer
I Garcia-Murillas, G Schiavon, B Weigelt, C Ng, S Hrebien, RJ Cutts, ...
Science translational medicine 7 (302), 302ra133-302ra133, 2015
9302015
Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma
D Mattos-Arruda, R Mayor, CKY Ng, B Weigelt, F MartÝnez-Ricarte, ...
Nature communications 6 (1), 1-6, 2015
5112015
Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle
L De Mattos-Arruda, B Weigelt, J Cortes, HH Won, CKY Ng, P Nuciforo, ...
Annals of oncology 25 (9), 1729-1735, 2014
3352014
Spatial and temporal heterogeneity in high-grade serous ovarian cancer: a phylogenetic analysis
RF Schwarz, CKY Ng, SL Cooke, S Newman, J Temple, AM Piskorz, ...
PLoS medicine 12 (2), e1001789, 2015
3242015
Genomic characterization of metastatic breast cancers
F Bertucci, CKY Ng, A Patsouris, N Droin, S Piscuoglio, N Carbuccia, ...
Nature 569 (7757), 560-564, 2019
3142019
Breast cancer intra-tumor heterogeneity
LG Martelotto, CKY Ng, S Piscuoglio, B Weigelt, JS Reis-Filho
Breast Cancer Research 16 (3), 1-11, 2014
2852014
Breast cancer intra-tumor heterogeneity
LG Martelotto, CKY Ng, S Piscuoglio, B Weigelt, JS Reis-Filho
Breast Cancer Research 16 (3), 1-11, 2014
2852014
Progression from ductal carcinoma in situ to invasive breast cancer: revisited
CF Cowell, B Weigelt, RA Sakr, CKY Ng, J Hicks, TA King, JS Reis-Filho
Molecular oncology 7 (5), 859-869, 2013
2792013
Chromosomal instability determines taxane response
C Swanton, B Nicke, M Schuett, AC Eklund, C Ng, Q Li, T Hardcastle, ...
Proceedings of the National Academy of Sciences 106 (21), 8671-8676, 2009
2662009
A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)
J Mateo, D Chakravarty, R Dienstmann, S Jezdic, A Gonzalez-Perez, ...
Annals of Oncology 29 (9), 1895-1902, 2018
2402018
Organoid models of human liver cancers derived from tumor needle biopsies
S Nuciforo, I Fofana, MS Matter, T Blumer, D Calabrese, T Boldanova, ...
Cell reports 24 (5), 1363-1376, 2018
2032018
Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands
I Weinreb, S Piscuoglio, LG Martelotto, D Waggott, CKY Ng, ...
Nature genetics 46 (11), 1166-1169, 2014
1832014
SF3B1 mutations constitute a novel therapeutic target in breast cancer
SL Maguire, A Leonidou, P Wai, C Marchi˛, CKY Ng, A Sapino, ...
The Journal of pathology 235 (4), 571-580, 2015
1812015
Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma
SL Cooke, CKY Ng, N Melnyk, MJ Garcia, T Hardcastle, J Temple, ...
Oncogene 29 (35), 4905-4913, 2010
1742010
Diverse BRCA1 and BRCA2 reversion mutations in circulating cell-free DNA of therapy-resistant breast or ovarian cancer
B Weigelt, I Comino-MÚndez, I de Bruijn, L Tian, JL Meisel, ...
Clinical Cancer Research 23 (21), 6708-6720, 2017
1602017
Massively parallel sequencing-based clonality analysis of synchronous endometrioid endometrial and ovarian carcinomas
AM Schultheis, CKY Ng, MR De Filippo, S Piscuoglio, GS Macedo, ...
Journal of the National Cancer Institute 108 (6), djv427, 2016
1312016
Benchmarking mutation effect prediction algorithms using functionally validated cancer-related missense mutations
LG Martelotto, CKY Ng, MR De Filippo, Y Zhang, S Piscuoglio, RS Lim, ...
Genome biology 15 (10), 1-20, 2014
1302014
A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations
S Kohsaka, N Shukla, N Ameur, T Ito, CKY Ng, L Wang, D Lim, ...
Nature genetics 46 (6), 595-600, 2014
1302014
The genomic landscape of male breast cancers
S Piscuoglio, CKY Ng, MP Murray, E Guerini-Rocco, LG Martelotto, ...
Clinical Cancer Research 22 (16), 4045-4056, 2016
1262016
Intra-tumor genetic heterogeneity and alternative driver genetic alterations in breast cancers with heterogeneous HER2 gene amplification
CKY Ng, LG Martelotto, A Gauthier, HC Wen, S Piscuoglio, RS Lim, ...
Genome biology 16 (1), 1-21, 2015
1252015
Il sistema al momento non pu˛ eseguire l'operazione. Riprova pi¨ tardi.
Articoli 1–20